Global Vaccine Conjugate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 202083
  • calendar_today Published On: Sep, 2019
  • file_copy Pages: 118
  • list Chemicals and Materials

Scope of the Report:

The worldwide market for Vaccine Conjugate is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new study.

This report focuses on the Vaccine Conjugate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Merck & Co., Inc.

GlaxoSmithKline plc.

SutroVax Inc.

Fablife.

Pfizer

Sinovac Biotech Ltd.

Sanofi Pasteur SA.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monovalent

Multivalent

Others

Market Segment by Applications, can be divided into

Influenza

Meningococcal

Pneumococcal

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Vaccine Conjugate product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Vaccine Conjugate, with price, sales, revenue and global market share of Vaccine Conjugate in 2017 and 2018.

Chapter 3, the Vaccine Conjugate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Vaccine Conjugate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Vaccine Conjugate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Vaccine Conjugate sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Vaccine Conjugate Introduction

1.2 Market Analysis by Type

1.2.1 Monovalent

1.2.2 Multivalent

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Influenza

1.3.2 Meningococcal

1.3.3 Pneumococcal

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Merck & Co., Inc.

2.1.1 Business Overview

2.1.2 Vaccine Conjugate Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck & Co., Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 GlaxoSmithKline plc.

2.2.1 Business Overview

2.2.2 Vaccine Conjugate Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GlaxoSmithKline plc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 SutroVax Inc.

2.3.1 Business Overview

2.3.2 Vaccine Conjugate Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 SutroVax Inc. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Fablife.

2.4.1 Business Overview

2.4.2 Vaccine Conjugate Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Fablife. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Vaccine Conjugate Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Sinovac Biotech Ltd.

2.6.1 Business Overview

2.6.2 Vaccine Conjugate Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Sanofi Pasteur SA.

2.7.1 Business Overview

2.7.2 Vaccine Conjugate Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Sanofi Pasteur SA. Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Vaccine Conjugate Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Vaccine Conjugate Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Vaccine Conjugate Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Vaccine Conjugate Manufacturer Market Share in 2018

3.3.2 Top 6 Vaccine Conjugate Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Vaccine Conjugate Market Analysis by Regions

4.1 Global Vaccine Conjugate Sales, Revenue and Market Share by Regions

4.1.1 Global Vaccine Conjugate Sales and Market Share by Regions (2014-2019)

4.1.2 Global Vaccine Conjugate Revenue and Market Share by Regions (2014-2019)

4.2 North America Vaccine Conjugate Sales and Growth Rate (2014-2019)

4.3 Europe Vaccine Conjugate Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Vaccine Conjugate Sales and Growth Rate (2014-2019)

4.5 South America Vaccine Conjugate Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Vaccine Conjugate Sales and Growth Rate (2014-2019)

5 North America Vaccine Conjugate by Country

5.1 North America Vaccine Conjugate Sales, Revenue and Market Share by Country

5.1.1 North America Vaccine Conjugate Sales and Market Share by Country (2014-2019)

5.1.2 North America Vaccine Conjugate Revenue and Market Share by Country (2014-2019)

5.2 United States Vaccine Conjugate Sales and Growth Rate (2014-2019)

5.3 Canada Vaccine Conjugate Sales and Growth Rate (2014-2019)

5.4 Mexico Vaccine Conjugate Sales and Growth Rate (2014-2019)

6 Europe Vaccine Conjugate by Country

6.1 Europe Vaccine Conjugate Sales, Revenue and Market Share by Country

6.1.1 Europe Vaccine Conjugate Sales and Market Share by Country (2014-2019)

6.1.2 Europe Vaccine Conjugate Revenue and Market Share by Country (2014-2019)

6.2 Germany Vaccine Conjugate Sales and Growth Rate (2014-2019)

6.3 UK Vaccine Conjugate Sales and Growth Rate (2014-2019)

6.4 France Vaccine Conjugate Sales and Growth Rate (2014-2019)

6.5 Russia Vaccine Conjugate Sales and Growth Rate (2014-2019)

6.6 Italy Vaccine Conjugate Sales and Growth Rate (2014-2019)

7 Asia-Pacific Vaccine Conjugate by Country

7.1 Asia-Pacific Vaccine Conjugate Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Vaccine Conjugate Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Vaccine Conjugate Revenue and Market Share by Country (2014-2019)

7.2 China Vaccine Conjugate Sales and Growth Rate (2014-2019)

7.3 Japan Vaccine Conjugate Sales and Growth Rate (2014-2019)

7.4 Korea Vaccine Conjugate Sales and Growth Rate (2014-2019)

7.5 India Vaccine Conjugate Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Vaccine Conjugate Sales and Growth Rate (2014-2019)

8 South America Vaccine Conjugate by Country

8.1 South America Vaccine Conjugate Sales, Revenue and Market Share by Country

8.1.1 South America Vaccine Conjugate Sales and Market Share by Country (2014-2019)

8.1.2 South America Vaccine Conjugate Revenue and Market Share by Country (2014-2019)

8.2 Brazil Vaccine Conjugate Sales and Growth Rate (2014-2019)

8.3 Argentina Vaccine Conjugate Sales and Growth Rate (2014-2019)

8.4 Colombia Vaccine Conjugate Sales and Growth Rate (2014-2019)

9 Middle East and Africa Vaccine Conjugate by Countries

9.1 Middle East and Africa Vaccine Conjugate Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Vaccine Conjugate Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Vaccine Conjugate Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Vaccine Conjugate Sales and Growth Rate (2014-2019)

9.3 Turkey Vaccine Conjugate Sales and Growth Rate (2014-2019)

9.4 Egypt Vaccine Conjugate Sales and Growth Rate (2014-2019)

9.5 Nigeria Vaccine Conjugate Sales and Growth Rate (2014-2019)

9.6 South Africa Vaccine Conjugate Sales and Growth Rate (2014-2019)

10 Global Vaccine Conjugate Market Segment by Type

10.1 Global Vaccine Conjugate Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Vaccine Conjugate Sales and Market Share by Type (2014-2019)

10.1.2 Global Vaccine Conjugate Revenue and Market Share by Type (2014-2019)

10.2 Monovalent Sales Growth and Price

10.2.1 Global Monovalent Sales Growth (2014-2019)

10.2.2 Global Monovalent Price (2014-2019)

10.3 Multivalent Sales Growth and Price

10.3.1 Global Multivalent Sales Growth (2014-2019)

10.3.2 Global Multivalent Price (2014-2019)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2014-2019)

10.4.2 Global Others Price (2014-2019)

11 Global Vaccine Conjugate Market Segment by Application

11.1 Global Vaccine Conjugate Sales Market Share by Application (2014-2019)

11.2 Influenza Sales Growth (2014-2019)

11.3 Meningococcal Sales Growth (2014-2019)

11.4 Pneumococcal Sales Growth (2014-2019)

11.5 Others Sales Growth (2014-2019)

12 Vaccine Conjugate Market Forecast (2019-2024)

12.1 Global Vaccine Conjugate Sales, Revenue and Growth Rate (2019-2024)

12.2 Vaccine Conjugate Market Forecast by Regions (2019-2024)

12.2.1 North America Vaccine Conjugate Market Forecast (2019-2024)

12.2.2 Europe Vaccine Conjugate Market Forecast (2019-2024)

12.2.3 Asia-Pacific Vaccine Conjugate Market Forecast (2019-2024)

12.2.4 South America Vaccine Conjugate Market Forecast (2019-2024)

12.2.5 Middle East and Africa Vaccine Conjugate Market Forecast (2019-2024)

12.3 Vaccine Conjugate Market Forecast by Type (2019-2024)

12.3.1 Global Vaccine Conjugate Sales Forecast by Type (2019-2024)

12.3.2 Global Vaccine Conjugate Market Share Forecast by Type (2019-2024)

12.4 Vaccine Conjugate Market Forecast by Application (2019-2024)

12.4.1 Global Vaccine Conjugate Sales Forecast by Application (2019-2024)

12.4.2 Global Vaccine Conjugate Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Vaccine Conjugate Picture

Table Product Specifications of Vaccine Conjugate

Figure Global Sales Market Share of Vaccine Conjugate by Types in 2018

Table

Please fill the form below, to recieve the report sample


+1